Latest Articles

Article

Mar 26, 2026

GOLD 2026 Report: Key Updates for COPD Management

What’s New in the GOLD 2026 Report

Learn more

Article

Mar 10, 2026

Understanding 6‑Month CDP in MS: An Overview with Dr. Barry Singer

A simplified walkthrough of how 6‑month Confirmed Disability Progression (CDP) is measured in MS clinical trials. Dr. Barry Singer explains how EDSS changes are assessed, why sustained progression matters, and how this endpoint helps distinguish real, lasting disability worsening from temporary fluctuations.

Learn more

Article

Mar 10, 2026

Understanding PIRA in MS: An Overview with Dr. Barry Singer

Progression Independent of Relapse Activity (PIRA) represents the gradual, sustained worsening of disability that occurs even without relapses. In this video, Dr. Barry Singer explains how PIRA is defined, why it affects many patients across the MS spectrum, and how clinicians can better detect subtle changes that reflect true long-term progression.

Learn more

Article

Mar 10, 2026

Understanding Kaplan–Meier Curves in MS: An Overview with Dr. Barry Singer

Kaplan–Meier curves play a key role in visualizing how clinical events—such as confirmed disability progression—evolve over time in MS studies. In this video, Dr. Barry Singer provides a clear, simplified walkthrough of how these curves are constructed, how patient data contributes to each step, and what curve separation really tells us about treatment impact. This resource offers an accessible foundation for anyone looking to better understand KM interpretation in MS research.

Learn more

Article

Mar 2, 2026

Flu in High Risk Population

Flu can lead to severe complications in high-risk populations, including older adults, pregnant women, and patients with chronic or immunocompromising conditions. This section provides key clinical insights, prevention strategies, and vaccination considerations to support healthcare professionals in protecting vulnerable patients and improving outcomes.

Learn more